Determination of the animal origin of 81 crude heparin samples using elisa technology

Ended Purchase Order Awarded Last action

Contract number
HHSF223201300210P
Awardee
Awarding agency
Obligated
$20,438

Award facts

Contract value 100% obligated
$20,437.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
St. Louis, MO 63101, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $5,056
Original award $15,382

About this award

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Immuno Diffusion Biotechnologies, a self-certified small disadvantaged business. The contract is for the determination of the animal origin of 81 crude heparin samples using ELISA technology. The contract has a ceiling value of $20,437.50 and a period of performance ending on July 8, 2013. This contract was not set aside for any specific business type.

Quick answers

Who was awarded contract HHSF223201300210P?

HHSF223201300210P was awarded to Immuno Diffusion Biotechnologies by Food and Drug Administration (Department of Health and Human Services) on April 8, 2013.

How much is contract HHSF223201300210P worth?

The government has obligated $20,438 on HHSF223201300210P.

Was contract HHSF223201300210P competed?

The extent of competition for HHSF223201300210P was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award